Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time

American Journal of Human Genetics

Volumn 86, Issue 4, 2010, Pages 626-631

  Houlihan, Lorna M ^a   Davies, Gail ^a   Tenesa, Albert ^b   Harris, Sarah E ^a   Luciano, Michelle ^a   Gow, Alan J ^a   McGhee, Kevin A ^a   Liewald, David C ^a   Porteous, David J ^a   Starr, John M ^a   Lowe, Gordon D ^c   Visscher, Peter M ^d   Deary, Ian J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; F12 GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HRG GENE; HUMAN; KNG1 GENE; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

AGED; BLOOD COAGULATION DISORDERS, INHERITED; CASE-CONTROL STUDIES; COHORT STUDIES; FACTOR XII; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KININOGENS; MALE; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; THROMBOSIS;

EID: 77950334578     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2010.02.016     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention (CDC). Mortality from coronary heart disease and acute myocardial infarction-United States, 1998. MMWR Morb. Mortal. Wkly. Rep. 50 (2001) 90-93
2. Lowe G.D., Rumley A., Woodward M., Reid E., and Rumley J. Activated protein C resistance and the FV:R506Q mutation in a random population sample-associations with cardiovascular risk factors and coagulation variables. Thromb. Haemost. 81 (1999) 918-924
3. Lowe G.D., Haverkate F., Thompson S.G., Turner R.M., Bertina R.M., Turpie A.G., and Mannucci P.M. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT Study. European Concerted Action on Thrombosis. Thromb. Haemost. 81 (1999) 879-886
4. Warren D.M., Soria J.M., Souto J.C., Comuzzie A., Fontcuberta J., Blangero J., MacCluer J.W., and Almasy L. Heritability of hemostasis phenotypes and their correlation with type 2 diabetes status in Mexican Americans. Hum. Biol. 77 (2005) 1-15
5. Souto J.C., Almasy L., Borrell M., Garí M., Martínez E., Mateo J., Stone W.H., Blangero J., and Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 101 (2000) 1546-1551
6. Souto J.C., Almasy L., Borrell M., Blanco-Vaca F., Mateo J., Soria J.M., Coll I., Felices R., Stone W., Fontcuberta J., and Blangero J. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: The GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am. J. Hum. Genet. 67 (2000) 1452-1459
7. Deary I.J., Gow A.J., Taylor M.D., Corley J., Brett C., Wilson V., Campbell H., Whalley L.J., Visscher P.M., Porteous D.J., and Starr J.M. The Lothian Birth Cohort 1936: A study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 7 (2007) 28
8. Deary I.J., Whiteman M.C., Starr J.M., Whalley L.J., and Fox H.C. The impact of childhood intelligence on later life: Following up the Scottish mental surveys of 1932 and 1947. J. Pers. Soc. Psychol. 86 (2004) 130-147
9. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., and Sham P.C. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81 (2007) 559-575
10. Ge D., Zhang K., Need A.C., Martin O., Fellay J., Urban T.J., Telenti A., and Goldstein D.B. WGAViewer: Software for genomic annotation of whole genome association studies. Genome Res. 18 (2008) 640-643
11. Li Y., and Abecasis G.R. Mach 1.0: Rapid haplotype reconstruction and missing genotype inference. Am. J. Hum. Genet. S79 (2006) 2290
12. Jensen L.J., Kuhn M., Stark M., Chaffron S., Creevey C., Muller J., Doerks T., Julien P., Roth A., Simonovic M., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37 Database issue (2009) D412-D416
13. Kumar P., Henikoff S., and Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4 (2009) 1073-1081
14. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res. 30 (2002) 3894-3900
15. Calafell F., Almasy L., Sabater-Lleal M., Buil A., Mordillo C., Ramírez-Soriano A., Sikora M., Souto J.C., Blangero J., Fontcuberta J., and Soria J.M. Sequence variation and genetic evolution at the human F12 locus: Mapping quantitative trait nucleotides that influence FXII plasma levels. Hum. Mol. Genet. 19 (2010) 517-525
16. Santamaría A., Mateo J., Tirado I., Oliver A., Belvís R., Martí-Fábregas J., Felices R., Soria J.M., Souto J.C., and Fontcuberta J. Homozygosity of the T allele of the 46 C>T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population. Stroke 35 (2004) 1795-1799
17. Tirado I., Soria J.M., Mateo J., Oliver A., Souto J.C., Santamaria A., Felices R., Borrell M., and Fontcuberta J. Association after linkage analysis indicates that homozygosity for the 46C>T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb. Haemost. 91 (2004) 899-904
18. Zhao W., Wang Y., Wang L., Lu X., Yang W., Huang J., Chen S., and Gu D. Gender-specific association between the kininogen 1 gene variants and essential hypertension in Chinese Han population. J. Hypertens. 27 (2009) 484-490
19. Barbalic M., Schwartz G.L., Chapman A.B., Turner S.T., and Boerwinkle E. Kininogen (KNG) gene variation has a consistent effect on aldosterone response to antihypertensive drug therapy: The GERA study. Physiol Genomics. 39 (2009) 56-60
20. Merkulov S., Zhang W.M., Komar A.A., Schmaier A.H., Barnes E., Zhou Y., Lu X., Iwaki T., Castellino F.J., Luo G., and McCrae K.R. Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 111 (2008) 1274-1281
21. Jones A.L., Hulett M.D., and Parish C.R. Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol. Cell Biol. 83 (2005) 106-118
22. Li Y., Bezemer I.D., Rowland C.M., Tong C.H., Arellano A.R., Catanese J.J., Devlin J.J., Reitsma P.H., Bare L.A., and Rosendaal F.R. Genetic variants associated with deep vein thrombosis: The F11 locus. J. Thromb. Haemost. 7 (2009) 1802-1808
23. Quélin F., Trossaërt M., Sigaud M., Mazancourt P.D., and Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J. Thromb. Haemost. 2 (2004) 71-76
24. Mitchell M., Cutler J., Thompson S., Moore G., Jenkins Ap Rees E., Smith M., Savidge G., and Alhaq A. Heterozygous factor XI deficiency associated with three novel mutations. Br. J. Haematol. 107 (1999) 763-765